Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Gross Margin (2020 - 2025)

Celularity (CELU) has disclosed Gross Margin for 5 consecutive years, with 26.12% as the latest value for Q3 2025.

  • On a quarterly basis, Gross Margin fell 3211.0% to 26.12% in Q3 2025 year-over-year; TTM through Sep 2025 was 13.36%, a 4063.0% decrease, with the full-year FY2024 number at 72.36%, up 4269.0% from a year prior.
  • Gross Margin was 26.12% for Q3 2025 at Celularity, up from 8.61% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 209.52% in Q4 2022 to a low of 967.3% in Q4 2024.
  • A 5-year average of 8.76% and a median of 72.7% in 2023 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: soared 11881bps in 2022, then plummeted -94733bps in 2024.
  • Celularity's Gross Margin stood at 90.71% in 2021, then surged by 131bps to 209.52% in 2022, then crashed by -110bps to 19.96% in 2023, then crashed by -4745bps to 967.3% in 2024, then soared by 103bps to 26.12% in 2025.
  • Per Business Quant, the three most recent readings for CELU's Gross Margin are 26.12% (Q3 2025), 8.61% (Q2 2025), and 68.9% (Q1 2025).